Recently added

Gender and sex differences in colorectal cancer screening, diagnosis and treatment

Gónzalez Flores, Encarnación; Elez, Elena; Redondo-Cerezo, Eduardo; Safont , Maria Jose; Vera, Ruth; García Carbonero, Rocío (Springer, 2025-07)

Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)

ITALIANO, ANTOINE; Gambardella, Valentina; Accordino, Melissa; Bedard, Philippe; Cervantes, Andrés; Hamilton, Erika; Oliveira, Mafalda; Saura Manich, Cristina (Elsevier, 2025-07)

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study

Sergi, Maria Chiara; Rasch, Marie-Lena; Benannoune, Naima; mandala, mario; Amaral, Teresa; Rutkowski, Piotr; MUÑOZ COUSELO, EVA (Elsevier, 2025-07-25)

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment

Kurzrock, Razelle; Magidi, Shai; BRESSON, CATHERINE; Wunder, Fanny; Hernando-Calvo, Alberto; Saoudi Gonzalez, Nadia; Martin Casado, Agatha (Impact Journals, 2025-06-17)

Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus

Dettmer, Matthias; Führer-Sakel, Dagmar; Hadoux, Julien; Ryska, Ales; Capdevila Castillon, Jaume; ELISEI, ROSSELLA (Bioscientifica, 2025-08)

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Gender and sex differences in colorectal cancer screening, diagnosis and treatment

Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment

Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus

Scientia. Department of Health Digital Information Depot

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Gender and sex differences in colorectal cancer screening, diagnosis and treatment ﻿

Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374) ﻿

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study ﻿

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment ﻿

Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus ﻿

Gender and sex differences in colorectal cancer screening, diagnosis and treatment

Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)

Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study

Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment

Molecular predictive biomarker testing in advanced thyroid cancer – a European consensus